Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the Ame
![Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/68ca0cc8-ba61-4bb5-aa35-b798530f3551/e927fig03.gif)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
![Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study - The Lancet Child & Adolescent Health Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study - The Lancet Child & Adolescent Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f337c396-5bb0-4b46-a6c3-6c1d02d54d8d/gr1.gif)
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study - The Lancet Child & Adolescent Health
![Flow chart reference for the management of refractory and incomplete... | Download Scientific Diagram Flow chart reference for the management of refractory and incomplete... | Download Scientific Diagram](https://www.researchgate.net/publication/221845871/figure/fig1/AS:509905548976128@1498582364651/Flow-chart-reference-for-the-management-of-refractory-and-incomplete-Kawasaki-disease.png)
Flow chart reference for the management of refractory and incomplete... | Download Scientific Diagram
![Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5d113c51-9037-44ef-bf21-ef221a51cd49/gr1.gif)
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
![National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría (English Edition) National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría (English Edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2341287918301406:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9/qVHBXBqbSQ7FNUvNof+6+l4v03CmyaR9Rm+q8TRfDEOS68CZK9bYY3KxU3zGztanBlteDayc3/6fH+YvoQ2fMAWIHV9b+ThkchP2KLIwTjnIUOi1XxUN79VNA04rve3lfKwLhXphPFxqAQi5bz38BHS52IUaeZvXfLy+Y/lgJub3mnMUWaqptQe9GJCKC2cU5c+8jRiK3cq88/X8Lu722aboh6ybgrjeNUpjUXH8reoOSF6viLq2xzdlyaa1UgLNaBby8I6k7v9Wd3JqSmfs14+ihwMN/YtNqt8LvGFXhW)
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría (English Edition)
![emDOCs.net – Emergency Medicine EducationEM in 5: Kawasaki Disease - emDOCs.net - Emergency Medicine Education emDOCs.net – Emergency Medicine EducationEM in 5: Kawasaki Disease - emDOCs.net - Emergency Medicine Education](http://www.emdocs.net/wp-content/uploads/2018/07/Screen-Shot-2018-07-22-at-7.23.58-PM-1024x567.png)